Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Sreenan

Showing results (21-30 of 40) with videos related to

Pageof 4
Sort By:
Diabetes|May 20, 1999
Increased beta-cell proliferation and reduced mass before diabetes onset in the nonobese diabetic mouseS Sreenan, A J Pick, M Levisetti, et al.
Irish Journal of Medical Science|June 3, 2008
ACTH-secreting bronchial carcinoid: a diagnostic and therapeutic challengeJ H McDermott, H Thabit, N Hickey, et al.
Endocrinology, Diabetes & Metabolism Case Reports|March 12, 2014
A silent myocardial infarction in the diabetes outpatient clinic: case report and review of the literatureM S Draman, H Thabit, T J Kiernan, et al.
Irish Journal of Medical Science|July 29, 2006
Prevalence of anaemia in patients with diabetes mellitusT J Cawood, U Buckley, A Murray, et al.
Diabetes, Obesity & Metabolism|November 24, 2007
Transferring to insulin detemir from NPH insulin or insulin glargine in type 2 diabetes patients on basal-only therapy with oral antidiabetic drugs improves glycaemic control and reduces weight gain and risk of hypoglycaemia: 14-week follow-up data from PREDICTIVEA Dornhorst, H-J Lüddeke, C Koenen, et al.
Endocrinology, Diabetes & Metabolism Case Reports|May 22, 2023
Central serous chorioretinopathy secondary to intramuscular testosterone therapyM Lockhart, E Ali, M Mustafa, et al.
Diabetes, Obesity & Metabolism|March 30, 2007
PREDICTIVE- a global, prospective observational study to evaluate insulin detemir treatment in types 1 and 2 diabetes: baseline characteristics and predictors of hypoglycaemia from the European cohortH-J Lüddeke, S Sreenan, S Aczel, et al.
International Journal of Clinical Practice|March 8, 2008
Insulin detemir improves glycaemic control without weight gain in insulin-naïve patients with type 2 diabetes: subgroup analysis from the PREDICTIVE studyA Dornhorst, H-J Lüddeke, S Sreenan, et al.
International Journal of Clinical Practice|February 23, 2007
Safety and efficacy of insulin detemir in clinical practice: 14-week follow-up data from type 1 and type 2 diabetes patients in the PREDICTIVE European cohortA Dornhorst, H-J Lüddeke, S Sreenan, et al.
Diabetes Research and Clinical Practice|September 29, 2009
Utilization of Frontal Assessment Battery and Executive Interview 25 in assessing for dysexecutive syndrome and its association with diabetes self-care in elderly patients with type 2 diabetes mellitusH Thabit, S M Kennelly, A Bhagarva, et al.
Pageof 4

Showing results (21-30 of 40) with videos related to

Sort By:
Pageof 4
Diabetes|May 20, 1999
Increased beta-cell proliferation and reduced mass before diabetes onset in the nonobese diabetic mouseS Sreenan, A J Pick, M Levisetti, et al.
Irish Journal of Medical Science|June 3, 2008
ACTH-secreting bronchial carcinoid: a diagnostic and therapeutic challengeJ H McDermott, H Thabit, N Hickey, et al.
Endocrinology, Diabetes & Metabolism Case Reports|March 12, 2014
A silent myocardial infarction in the diabetes outpatient clinic: case report and review of the literatureM S Draman, H Thabit, T J Kiernan, et al.
Irish Journal of Medical Science|July 29, 2006
Prevalence of anaemia in patients with diabetes mellitusT J Cawood, U Buckley, A Murray, et al.
Diabetes, Obesity & Metabolism|November 24, 2007
Transferring to insulin detemir from NPH insulin or insulin glargine in type 2 diabetes patients on basal-only therapy with oral antidiabetic drugs improves glycaemic control and reduces weight gain and risk of hypoglycaemia: 14-week follow-up data from PREDICTIVEA Dornhorst, H-J Lüddeke, C Koenen, et al.
Endocrinology, Diabetes & Metabolism Case Reports|May 22, 2023
Central serous chorioretinopathy secondary to intramuscular testosterone therapyM Lockhart, E Ali, M Mustafa, et al.
Diabetes, Obesity & Metabolism|March 30, 2007
PREDICTIVE- a global, prospective observational study to evaluate insulin detemir treatment in types 1 and 2 diabetes: baseline characteristics and predictors of hypoglycaemia from the European cohortH-J Lüddeke, S Sreenan, S Aczel, et al.
International Journal of Clinical Practice|March 8, 2008
Insulin detemir improves glycaemic control without weight gain in insulin-naïve patients with type 2 diabetes: subgroup analysis from the PREDICTIVE studyA Dornhorst, H-J Lüddeke, S Sreenan, et al.
International Journal of Clinical Practice|February 23, 2007
Safety and efficacy of insulin detemir in clinical practice: 14-week follow-up data from type 1 and type 2 diabetes patients in the PREDICTIVE European cohortA Dornhorst, H-J Lüddeke, S Sreenan, et al.
Diabetes Research and Clinical Practice|September 29, 2009
Utilization of Frontal Assessment Battery and Executive Interview 25 in assessing for dysexecutive syndrome and its association with diabetes self-care in elderly patients with type 2 diabetes mellitusH Thabit, S M Kennelly, A Bhagarva, et al.
Pageof 4